Stay updated on Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page.

Latest updates to the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page
- Check4 days agoChange DetectedA site-wide banner announces an NIH terminology transition, and the displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe footer revision label was updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check32 days agoChange DetectedRemoved key study documents and metadata from the record, including PDFs and location/arm information, thereby altering the materials and context available for the long-term extension study.SummaryDifference18%

- Check39 days agoChange DetectedThe page's underlying platform version was upgraded from v3.6.6 to v3.7.0, representing a software update.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page’s revision label was updated to v3.6.6, signaling a new revision of the study record.SummaryDifference0.0%

- Check75 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, indicating a minor maintenance update to the page's version. The change does not modify the study details or display content.SummaryDifference0.0%

Stay in the know with updates to Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page.